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Cardiovascular
Cardiac failure: epidemiology and treatment
Mebazaa and colleagues in two interesting papers [1, 2]
described the clinical presentation, management, and
outcomes of acute heart failure (AHF) through the Acute
Heart Failure Global Survey of Standard Treatment
(ALARM-HF) on AHF conducted in nine countries in
four continents. In the ﬁrst paper [1] data from 4,953
patients with AHF were collected via questionnaire from
666 hospitals. Clinical presentation included
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edema (36.7%), and cardiogenic shock (11.7%). Patients
with a de novo episode of AHF (36.2%) were younger,
had less comorbidities and lower blood pressure despite
greater left ventricular ejection fraction (LVEF), and were
more often admitted to ICU. Overall, intravenous (IV)
diuretics were given in 89.7%, vasodilators in 41.1%, and
inotropic agents (dobutamine, dopamine, adrenaline,
noradrenaline, and levosimendan) in 39% of cases. Hos-
pital death rate was 12%, the majority due to cardiogenic
shock (43%). More patients with de novo AHF (14.2%)
than patients with a pre-existing episode of AHF (10.8%)
(p = 0.0007) died. There was graded mortality in inten-
sive care unit (ICU), critical care unit (CCU), and ward
patients with mortality in ICU patients being the highest
(17.8%) (p\0.0001). The conclusion stressed the con-
cept that the recognition of subgroups might improve
management and outcome by deﬁning speciﬁc therapeutic
requirements.
The second study [2] identiﬁed the risks and beneﬁts
of IV drugs in patients hospitalized with acute decom-
pensated heart failure. In this post hoc analysis of
ALARM-HF data, the authors used the propensity scoring
to identify groups of patients who differed by treatment
but had the same multivariate distribution of covariates,
allowing the estimations of the effect of speciﬁc treat-
ments on the outcome of in-hospital mortality.
Unadjusted analysis showed a lower in-hospital mortality
rate in AHF patients receiving ‘‘diuretics ? vasodilators’’
(n = 1,805) compared with those receiving ‘‘diuretics
alone’’ (n = 2,362) (7.6 vs. 14.2%, p\0.0001). Pro-
pensity-based matching (n = 1,007 matched pairs)
conﬁrmed the lower mortality of AHF patients receiving
diuretics ? vasodilators: 7.8 versus 11.0% (p = 0.016).
The authors concluded that in terms of in-hospital sur-
vival, a vasodilator in combination with a diuretic fared
better than treatment with only a diuretic. Catecholamine
and inotropes should be used cautiously as it has been
seen that they actually increase the risk of in-hospital
mortality.
Extracorporeal circulation may assist a failing ventri-
cle: two papers have proposed clever solutions to speciﬁc
technical problems. Trimlett and co-workers [3] studied a
new technique of insertion of double-lumen bicaval
cannulas for venovenous extracorporeal membrane oxy-
genation (ECMO). The rationale is that vascular damage
or cardiac perforation may occur during cannulation, but
with the new technique this complication seems to have
been reduced.
In the study by Endemann and co-workers [4] a dif-
ferent approach was used for coronary artery
catheterization in patients during ECMO. The rationale
was that an additional puncture of the femoral artery for
the angiography carries a risk of complications, whereas
their new technique avoided the need for further punc-
tures. Instead they used the arterial lines that were already
inserted. They introduced a Y-connector in the arterial
cannula of the ECMO setup. At its free end a hemostatic
valve was placed, over which the coronary catheters were
inserted. This enabled the angiography to be performed
and no complications were noted in the limited number of
patients they had so far studied.
Cardiogenic shock leads to an inadequate tissue per-
fusion including a physiological reduction in the
splanchnic territory. The use of enteral nutrition is asso-
ciated with an increase in mesenteric arterial output, and
thus could be deleterious. On the other hand, mesenteric
arterial output may decrease during parenteral nutrition
administration, thus having a protective effect. Thibault
and colleagues [5] reviewed a number of issues related to
the safety of nutrition in patients with cardiogenic shock.
The combination of enteral nutrition with supplemental
parenteral nutrition during the ﬁrst days following ICU
admission has been proposed to prevent negative energy
balance, and such a nutritional strategy could also be
beneﬁcial for the mesenteric circulation and may improve
the clinical outcome of these patients. This hypothesis
needs to be conﬁrmed in future well-designed and con-
ducted studies.
Bloechlinger and co-authors [6] reviewed the present
knowledge on left ventricular rotation. Such rotation or
twisting may be an important mechanism of improving
cardiac pumping at reduced oxygen demand. They point
to a number of factors that can prevent or impede the
systolic twisting and its subsequent release during dias-
tole, factors that will impede the cardiac function. Better
understanding of cardiac twisting may guide in preserving
or enhancing it in order to improve cardiac pumping.
Impact of type of ﬂuid administration
Fluid administration is a key component of hemodynamic
resuscitation. As excessive ﬂuid administration may be
deleterious, identiﬁcation of ﬂuid-responsive patients is
desired. Several tests have been developed, mostly based
on the variability of stroke volume. Pulse pressure vari-
ations are frequently used as a surrogate of stroke volume
variations [7], but vascular compliance may distort arte-
rial waveform. Indeed, arterial pressure should ideally be
recorded centrally but is for practical reasons recorded in
more distal arteries. However, arterial compliance and
waveform reﬂection affect arterial waveform and may
thus also affect pulse pressure (and hence pulse pressure
variations). Dufour et al. [8] elegantly used an applanation
tonometry technique to reconstruct the aortic root wave-
form and compared central and peripheral pulse pressure
variations in 56 patients. This system includes a high-
ﬁdelity micromanometer that is applied to the surface of
the skin overlying the radial artery, the peripheral arterial
waveform is recorded, and central arterial pressure is
reconstructed after comparison with brachial artery
346pressure (measured noninvasively). Peripheral pulse pres-
sure was higher than central pulse pressure (55 ± 15 vs.
33 ± 14 mmHg), but peripheral and central pulse pressure
variations similarly predicted ﬂuid responsiveness.
In addition, there is still an intense debate on the ideal
type of ﬂuid that should be used for ﬂuid resuscitation. In
the large SAFE trial [9], which randomized 6,997 criti-
cally ill patients to receive either 4% albumin or normal
saline as resuscitation ﬂuid, there was no difference in
outcome in the whole population. In a planned subgroup
analysis, the authors focused on the 1,218 patients with
severe sepsis at baseline [10]. There were no differences
in baseline characteristics, except for mean arterial pres-
sure that was slightly higher in the saline group compared
with the albumin group (75 vs. 73, p = 0.03). Mortality at
28 days tended to be lower in the albumin than in the
saline group [30.7 vs. 35.3%, odds ratio (OR) 0.87
(0.74–1.02)]. After adjustment for baseline covariates,
albumin administration was associated with a signiﬁcant
decrease in the risk of death 0.71 (0.52–0.97). These
promising results should be conﬁrmed by a randomized
trial in patients with sepsis.
Artiﬁcial colloids, and especially hydroxyethyl star-
ches (HES), may be an alternative to albumin. However,
HES may be associated with impairment in renal function
[11]. However concerns were raised about the use of the
old generation of HES in these studies, often in large
amounts. Several large-scale randomized trials are cur-
rently ongoing in this domain (Clinicaltrials.gov.
NCT00962156/NCT00935168). Myburgh et al. [12]
published the protocol and analysis plan of the Crystalloid
versus Hydroxyethyl Starch Trial (CHEST). CHEST
(NCT00935168) aimed to randomize 7,000 critically ill
patients to receive either 6% HES (130/0.4) or sodium
chloride (0.9%) as sole resuscitation ﬂuid in order to
demonstrate an absolute difference of 3.5% in mortality at
90 days. Secondary outcomes include various indices of
organ dysfunction and especially renal injury. Inclusion
criteria are based on clinical signs (tachycardia, hypo-
tension, oliguria, capillary reﬁll time greater than 1 s) or
central venous pressure below 10 mmHg. One may crit-
icize that many of these signs are not speciﬁc of
hypovolemia. Subgroup analyses will be conducted in
four predeﬁned subgroups (trauma, traumatic brain injury,
sepsis, and pre-existing renal dysfunction).
A systematic review addressed the inﬂuence of HES
on hemostasis [13]. HES can reduce von Willebrand
factor and interfere with ﬁbrinogen polymerization and
platelet function. Newer HES 130/0.4 is said to be safer,
but a number of studies dealing with this product have
been retracted. Thus, the authors performed a systematic
review of studies assessing the effects of HES 130/0.4 on
hemostasis by thrombelastography (TEG, ROTEM) or
Sonoclot (SCR) in comparison with crystalloid or albu-
min control ﬂuids. Seventeen in vitro and seven in vivo
hemodilution studies were analyzed. Nineteen studies
showed a hypocoagulatory effect of HES 130/0.4 on clot
formation. Dose effects were apparent in the in vitro
studies, which investigated higher dilutions up to 80%.
In vivo studies were fewer and did not investigate doses
over 40 mL/kg. It was concluded that HES 130/0.4
administration is associated with hypocoagulation and
that safer ﬂuids, such as crystalloids, should be chosen for
patients at increased risk of bleeding.
Effects of vasoactive agents
The impact of hydrocortisone on vascular hyporeactivity
to adrenergic agents has long been recognized [14], but
the impact of hydrocortisone on vasopressin hypore-
sponsiveness is less well deﬁned. In a retrospective cohort
of 155 patients with septic shock receiving vasopressin,
Torgersen et al. [15] evaluated the impact of combined
treatment with hydrocortisone. Hydrocortisone was
administered to almost half of the patients (47.8%).
Concomitant use of AVP and hydrocortisone was asso-
ciated with a trend towards lower 28-day mortality
[hazard ratio (HR) 0.69, CI 95% 0.43–1.08, p = 0.11]. As
patients treated without and with hydrocortisone may not
have the same severity, the authors used a propensity
score to compare the two groups. This propensity score-
based analysis, which included 80 patients only, yielded
the same results (28-day mortality OR 0.59, CI 95%
0.27–1.29, p = 0.18). These results are in line with those
of a subgroup analysis of the VASST trial [16], which
also suggested some potential beneﬁt for the combination
of hydrocortisone and vasopressin. This should be tested
in future trials.
The microcirculatory effects of terlipressin, another
vasopressin derivate, are not well deﬁned and were
investigated this year [17]. The sublingual microcircula-
tion was investigated in 20 patients with septic shock just
before and 6 h after the administration of a 0.5-mg bolus
of terlipressin. Norepinephrine requirements decreased
from 0.74 ± 0.73 to 0.42 ± 0.67 lg/(kg min) (p\0.05),
while mean arterial was kept constant (around
70 mmHg). The total number of vessels was not affected
but perfusion of microvessels improved. Microcirculatory
ﬂow index of small vessels increased at the end of the 6-h
study period (from 2.0 ± 0.5 to 2.6 ± 0.6 units,
p\0.05), while heterogeneity index decreased. Given
the lack of control group and the time elapsed between
measurements, these results need to be conﬁrmed.
Evaluation of microcirculation
Several studies focused on microcirculation. Ait-Oufella
et al. [18] investigated whether mottling, a clinical sign
indicating impaired tissue perfusion, may be associated
with outcome in patients with septic shock. The authors
347included 60 consecutive patients and measured hemody-
namic variables. They also evaluated mottling around
knees, on admission and after 6 h. Mottling was scored
from 0 to 5, based on mottling area extension from the
knees to the periphery. Mottling score was not related to
arterial pressure or cardiac index. High mottling scores
were associated with elevated lactate levels, low urine
output, and high organ dysfunction scores. In addition, a
high mottling score on admission was associated with
poor outcome. More importantly, patients experiencing a
decrease in mottling score in response to resuscitation had
a better prognosis than those with stable or worsening of
the score (14-day mortality 12 vs. 77%, p = 0.0005).
Unfortunately, it is difﬁcult to determine whether mot-
tling reﬂects regional or microcirculatory perfusion.
Another trial [19] investigated tissue oxygen satura-
tion (StO2) determined by near-infrared spectroscopy as
an index of tissue perfusion, StO2 was measured in two
different locations (thenar and forearm) at two different
depths (1.5 and 2.5 mm) during simulated hypovolemia.
Lower body negative pressure was applied in ﬁve steps up
to -100 mmHg in 24 healthy volunteers. Hyovolemia
induced a progressive decrease in stroke volume down to
45% of baseline. StO2 decreased in the forearm (85%
from baseline) and also, but more modestly (95% from
baseline), in the thenar area. The decrease in StO2 was
similar at both depths, both in thenar and forearm areas.
This study shows that the position but not the depth of the
probe is relevant for the assessment of tissue perfusion
during hypovolemia. Of note, StO2 was less sensitive than
stroke volume to detect hypovolemia.
Cardiovascular monitoring
Intensive Care Medicine ﬁrst published the need for
widespread use of echocardiography in the ICU [20]. Our
journal was also the ﬁrst to publish an ‘‘International
expert statement on training standards for critical care
ultrasonography’’ endorsed by the European Society of
Intensive Care Medicine (ESICM) and 11 other national
and international societies of intensive care medicine
[21]. Indeed, echocardiography is helpful to assess the
diagnosis of a hemodynamic instability. Transesophageal
echo can even be used successfully in ARDS patients in
prone position [22]. We learned in recent years that tissue
Doppler imaging (TDI) is helpful in various conditions
such as weaning for either mechanical ventilation or
ECMO. Papanikolaou et al. [23] showed, in patients with
no history of cardiac failure, that failure to wean from
mechanical ventilation was associated with some degree
of left ventricular (LV) diastolic dysfunction. Lateral
early mitral inﬂow velocity to peak mitral annulus
velocity (E/Em) ratio was a strong independent factor
associated with weaning failure. Aissaoui et al. [24] also
showed a great interest in the use of TDI to predict
ECMO weaning success. Favorable systolic LV parame-
ters assess favorable outcome. Thus, aortic time–velocity
integral of at least 10 cm, LV ejection fraction greater
than 20–25%, and lateral mitral annulus peak systolic
velocity of at least 6 cm/s are associated with ECMO
weaning success.
The blood pressure signal provides information which
helps physicians to assess hemodynamic status and to
guide treatment. Augusto and colleagues [7] summarized
the physiological principles on which blood pressure
measurements are based. Arterial catheter allows for a
continuous and precise monitoring of arterial pressure
signal. The analysis of the blood pressure wave provides
information that may help the clinician to interpret
hemodynamic status, thus guiding ﬂuids and/or vasoac-
tive drugs administration. The physiological mechanisms
responsible for arterial pressure generation are explained.
In addition, the static and the dynamic indexes generated
by heart–lung interactions derived from the arterial
pressure wave are discussed. Finally, the recommended
target of mean blood pressure value is fully analyzed.
Arterial pressure-based cardiac output is indeed
increasingly used in intensive care medicine and in
operating rooms in high-risk surgical patients. In a pro-
spective multicentric validation trial, De Backer et al. [25]
showed improved validity of the data generated by the
third-generation FLoTrac compared with the second
generation, in septic patients. Further studies are needed
to conﬁrm the validity of those tools in the ICU.
Central venous saturation (ScvO2) is widely used in
the ICU to guide treatment and predict outcome. Perz
et al. [26] conﬁrmed ScvO2 as a great indicator of out-
come in the perioperative period. They ﬁrst conﬁrmed
that low ScvO2 is associated with poor outcome. They
further showed, surprisingly, that high ScvO2 also named
‘‘supra-normal’’ ScvO2 is under-recognized as a warning
sign of poor outcome. It is likely related to a marked
reduction of oxygen consumption as might be seen in
sepsis.
Infections, pneumonia, and sepsis
Infections
Hospital-acquired infections with antibiotic-resistant
bacteria are an important problem among critically ill
patients. Control of these organisms has largely focused
within individual hospitals. Karkada et al. [27] examined
the extent to which transfers of critically ill patients could
be a vector for the spread of such bacteria and compared
the efﬁciency of different infection control measures in a
simulation study of an American hospital network system.
Hospitals varied substantially in the importance placed on
limiting potential spread, and targeting resources to a
348small subset of hospitals on the basis of their position in
the transfer network was 16 times more efﬁcient than
distributing infection control resources uniformly.
Changes in the consumption of MRSA-active antibi-
otics and in the burden of MRSA between 2001 and 2009
were analyzed in a network of 55 German ICUs [28].
‘‘Old MRSA-active antibiotics’’ included vancomycin,
teicoplanin, and fosfomycin and ‘‘new MRSA-active
antibiotics’’ included quinupristin/dalfopristin, linezolid,
and daptomycin. Both the burden of MRSA and the
pooled mean MRSA resistance proportion did not change
signiﬁcantly over time. In contrast, MRSA-active antibi-
otics more than doubled from 44 deﬁned daily doses per
1,000 patient-days in 2001 to 92 in 2009. This was due to
the signiﬁcant increase of new MRSA-active antibiotics
(from 1 to 40), whereas old MRSA antibiotics stayed
stable (43 in 2001 and 52 in 2009).
Crandon and co-workers [29] developed a meropenem
population pharmacokinetic model in critically ill patients
with particular focus on optimizing dosing regimens
based on renal function. Initial modeling was performed
on 21 patients (55 samples) and validation was conducted
with 12 samples from 5 patients. The model was capable
of accurately estimating meropenem concentrations in
critically ill patients over a range of creatinine clearance
values. Compared with 0.5-h infusions, regimens
employing prolonged infusions improved target attain-
ment across all creatinine clearance ranges.
Selective decontamination of the digestive tract (SDD)
has received continued interest for the prevention of
infections. In a randomized trial in a Dutch ICU, SDD and
probiotics were compared [30]. The probiotics contained
Lactobacillus 299/299v plus ﬁber, administered two times
daily. The trial was prematurely stopped after a study
reporting increased mortality in critically ill pancreatitis
patients receiving probiotics [31]. There were no signiﬁ-
cant differences in infection rates [31% in the probiotic
group and 24% in the SDD group (OR 1.68, 95% CI
0.91–3.08, p = 0.10)].
Although SDD can signiﬁcantly decrease infection
rates (and possibly mortality) in ICU patients, it has not
been widely accepted and adopted possibly because of
fear of encouraging bacterial resistance to the antimicro-
bials used. To evaluate the long-term incidence of
carriage of antibiotic-resistant bacteria, its clinical impact
on developing infections, and to explore risk factors for
acquiring resistance, Ochoa-Ardila and colleagues con-
ducted a 5-year cohort study in 1,588 patients given SDD
[32]. Interestingly, long-term use of SDD in that study
was not associated with an increased resistance against
the antimicrobials used as part of the SDD, or with an
increase in the rate in infections caused by resistant
strains; in fact, a reduction in the incidence of P. aeru-
ginosa resistant to aminoglycosides was observed. These
ﬁndings are in line with those reported by de Smet et al.
[33], showing that the use of SDD was associated with a
reduction in acquired bacteremia and respiratory tract
colonization caused by highly resistant microorganisms
compared with standard care.
H1N1
Early use of corticosteroids in patients affected by pan-
demic (H1N1)v inﬂuenza A infection, although relatively
common, remains highly debated. In order to assess the
potential usefulness of such a treatment, Martin-Loeches
and colleagues [34] analyzed the chart records of 220
patients admitted to ICU with a conﬁrmed H1N1 infec-
tion, prospectively included in the European Society of
Intensive Care Medicine H1N1 registry. Among these
patients, 126 (57.3%) received corticosteroid therapy on
admission to ICU. They were signiﬁcantly older and were
more likely to have coexisting asthma, chronic obstruc-
tive pulmonary disease, and chronic steroid use. Cox
regression analysis adjusted for severity and potential
confounding factors identiﬁed that early use of cortico-
steroids was not signiﬁcantly associated with mortality
(HR 1.3, 95% CI 0.7–2.4, p = 0.4) but was still associ-
ated with an increased rate of hospital-acquired
pneumonia (OR 2.2, 95% CI 1.0–4.8, p\0.05). Very
similar ﬁndings were observed in two other large cohort
studies, the ﬁrst one by Kim et al. [35], and the second
one by Brun-Buisson et al. [36], conﬁrming that early use
of corticosteroids in patients affected by pandemic
(H1N1)v inﬂuenza A infection did not result in better
outcomes and was associated with increased risk of
superinfections.
Because some uncertainty about the severity of the
A(H1N1) pandemia persists, particularly regarding its
impact on the healthcare system, Bertolini and colleagues
[37] conducted a prospective observational study in 155
Italian ICUs contributing to the GiViTI national database
during the epidemic phase of the disease. At the epi-
demic’s peak (October–December 2009) the ICU
occupancy rate did not signiﬁcantly differ from the same
period of the previous year, and was signiﬁcantly lower
than the 2009 seasonal inﬂuenza outbreak (January–
March 2009). Compared with community-acquired
pneumonia (CAP) of other origin (3,678 patients),
A(H1N1) pneumonia was associated with the same risk of
death when potential confounders were taken into account
(OR 0.88, 95% CI 0.59–1.31, p = 0.52). Thus, on the
basis of these data, it seems that the pandemic did not
increase ICU workload compared with other periods, at
least in Italy. However, it is still true that the pandemic
affected many young people, and the burden in terms of
young lives lost cannot be overlooked.
In a retrospective observational study in 23 French
ICUs, Cuquemelle and co-workers [38] investigated
whether procalcitonin (PCT) levels could discriminate
isolated viral from mixed (bacterial and viral) pneumonia
349during the A/H1N1v2009 inﬂuenza pandemic. Of 103
patients with conﬁrmed A/H1N1 infection and not having
received prior antibiotics, 48 had a documented bacterial
co-infection (mostly caused by Streptococcus pneumo-
niae or Staphylococcus aureus). Median values of PCT
were signiﬁcantly higher in patients with bacterial co-
infection: 29.5 (3.9–45.3) versus 0.5 (0.12–2) lg/L
(p\0.01). For a cutoff of 0.8 lg/L or more, the sensi-
tivity and speciﬁcity of PCT for distinguishing isolated
viral from mixed pneumonia were 91 and 68%,
respectively.
MRSA pneumonia
Although vancomycin has been the mainstay for treat-
ment of MRSA infections, the drug may not be adequate
for patients with MRSA pneumonia, particularly when the
infection is caused by a strain with a relatively high
vancomycin minimal inhibitory concentration (MIC)
(C1.5 lg/mL). To assess the distribution of vancomycin
MICs in MRSA isolates and evaluate the efﬁcacy of
vancomycin relative to vancomycin MICs in adult
patients with MRSA nosocomial pneumonia, Choi and
colleagues [39] analyzed the clinical outcomes of 70
adults with MRSA nosocomial pneumonia treated with
vancomycin. Thirty-four (48.6%) isolates had high
(C1.5 lg/mL) vancomycin MICs, and 36 (51.4%) had
low (B 1 lg/mL) MICs, as determined by E test. Patients
infected with high-MIC strains showed slower clinical
response and higher relapse rate (29.6 vs. 6.9%,
p = 0.038) than patients infected with low-MIC vanco-
mycin isolates. Infection caused by high-MIC strains was
also an independent predictor of early clinical response
failure when tested on multivariate analysis. These results
are in accordance with those obtained by other investi-
gators in patients with MRSA bloodstream infections
[40].
Attributable mortality of ventilator-associated
pneumonia (VAP)
Determining the contribution of ICU-acquired pneumonia
to patients’ severity of illness and mortality is a major
challenge. In order to relate new organ dysfunction/failure
(OD/F) occurring during the ICU stay to clinical events,
Damas and colleagues [41] measured the SOFA score
daily in 453 adult patients with ICU-acquired pneumonia.
Although septic shock occurred in 21% of all cases of
ICU-acquired pneumonia, infection was responsible for
only a minor proportion of organ dysfunctions and/or
failures occurring during the ICU stay. Severity of ICU-
acquired pneumonia was essentially related to clinical
status prior to infection, but not to the type of bacteria.
These results are consistent with those recently reported
by Nguile-Makao et al. [42] and Bekaert et al. [43] using
multistate progressive disability models and causal anal-
ysis, detecting a relatively limited attributable ICU
mortality of VAP.
Community-acquired pneumonia
Emergency and ICU physicians often face the routine
challenge of predicting short- to mid-term adverse out-
comes for patients with CAP. As biomarkers have
signiﬁcantly improved practices in emergency medicine,
it was suggested that they could help management of
CAP, particularly when using endothelium-associated
peptides, such as precursor peptides of endothelin-1
(proET-1) that correlate closely with endothelial activa-
tion. Indeed, emerging evidence points to a critical role of
the endothelium in patients with systemic infections [44].
In this context, Schuetz and colleagues [45] evaluated the
prognostic information derived from repeated measure-
ments of proET-1 for monitoring patients during the
course of disease in a well-deﬁned cohort of 925 CAP
patients. They found that both admission proET-1 levels
and relative changes between baseline and day 3 provided
signiﬁcant prognostic information in regard to mortality
and the need for ICU admission and improved classiﬁ-
cation of the pneumonia severity index (PSI) score. The
results also showed that relative changes in the marker
level provided more information compared with absolute
marker levels during the follow-up. If veriﬁed in inter-
vention studies, monitoring of proET-1 may be helpful for
endothelium targeting therapies and for risk stratiﬁcation
complementary to other prohormones.
Two reviews addressed important issues in the ﬁeld of
CAP. The ﬁrst analyzed the four different validated rules
to help in the decision regarding ICU admission in
patients with CAP. Ewig and colleagues [46] critically
reviewed these rules: the modiﬁed American Thoracic
Society (ATS) rule, Infectious Diseases Society of
America (IDSA)/ATS rule, Espan ˜a rule, and SMART-
COP (systolic blood pressure, multilobar extension of
inﬁltrates, albumin, respiratory rate, tachycardia, confu-
sion, oxygen, and arterial pH). Their performance varies,
with sensitivity of around 70% and speciﬁcity of around
80–90%. Only negative predictive values are consistently
high. Critical methodological issues include the appro-
priate reference for derivation, the populations studied,
the variables included, and the time course of pneumonia.
Pneumonia-related complications and decompensated
comorbidities may be additional or independent reasons
for a severe course. The authors advocate an approach
that refers to the evaluation of the need for intensiﬁed
treatment rather than ICU, based on a set of minor criteria
but sensitive to the dynamic nature of pneumonia.
The second review pertained to the assessment of
severity to guide ICU admission [47]. Universally
350accepted criteria for ICU care in patients with CAP are
mechanical ventilation and/or vasopressor support. Chal-
mers and collaborators aimed to determine if severity
assessment tools could be used to guide decisions
regarding ICU admission of patients with CAP. To that
end, a meta-analysis of 28 studies and ﬁve scoring sys-
tems was performed. These scoring systems were the PSI,
the CURB65 (confusion, urea, respiratory rate, blood
pressure, and age[65) score, the CRB65 score, the ATS
2001 criteria, and the IDSA/ATS 2007 criteria. The PSI,
CURB65, and CRB65 performed similarly in terms of
sensitivity and speciﬁcity. Patients in CURB65 group zero
were at lowest risk of ICU admission (negative likelihood
ratio 0.14), whereas the ATS 2001 criteria had the highest
positive likelihood ratio (7.05). However, a marked het-
erogeneity between studies was detected. The authors
concluded that scoring systems designed to predict 30-day
mortality perform less well in predicting ICU admission.
Sepsis and septic shock
Severe sepsis is associated with high mortality, and the
Surviving Sepsis Campaign (SSC) protocol was devel-
oped as an international initiative to reduce mortality.
Cost-effectiveness of the SSC protocol for the treatment
of severe sepsis was determined in 59 Spanish ICUs in an
observational prospective before-and-after study after the
implementation of an educational program compared with
the conventional care of severe sepsis [48]. Patients in the
SSC protocol care cohort (n = 1,465) had a lower risk of
hospital mortality (44.0 vs. 39.7%, p = 0.04), but mean
costs per patient were 1,736 euros higher, largely as a
result of increased length of stay. The adjusted incre-
mental cost-effectiveness ratio (ICER) of the SSC
protocol was 4,435 euros per life years gained.
An option still debated is the use of steroids for severe
sepsis and septic shock. Three recent meta-analyses on
the effects of low-dose corticosteroids on mortality
reduction in patients with severe sepsis and septic shock
gave contradictory results: two showed potential mortality
beneﬁt and one showed no mortality beneﬁt. In the March
issue Kalil and Sun [49] assessed the efﬁcacy and safety
of low-dose steroids for severe sepsis and septic shock by
Bayesian methodology. Relative risk reductions (RRR)
for 28-day mortality and relative risk increases (RRI) for
shock reversal and side effects were estimated. The
authors found that in septic shock trials only (Marik meta-
analysis), the probability that low-dose steroids decrease
mortality by more than 15% (i.e., RRR[15%) was 0.41
(0.24 for RRR[20% and 0.14 for RRR[25%). For
severe sepsis and septic shock trials combined, the results
were as follows: (1) for the Annane meta-analysis, the
probabilities were 0.57 (RRR[15%), 0.32 (RRR[
20%), and 0.13 (RRR[25%); (2) for the Minneci meta-
analysis, the probability was 0.57 to achieve mortality
RRR[15%, 0.32 (RRR[20%), and 0.14 (RRR[
25%). The probability of achieving shock reversal ranged
from 65 to 92%. The probability of developing steroid-
induced side effects was as follows: for gastrointestinal
bleeding (n = 924), there was a 0.73 probability of ste-
roids causing an RRI[1%, 0.70 for RRI[2%, and 0.67
for RRI[5%; for superinfections (n = 964), probabili-
ties were 0.81 (RRI[1%), 0.76 (RRI[2%), and 0.70
(RRI[5%); and for hyperglycemia (n = 540), 0.99
(RRI[1%), 0.97 (RRI[2%), and 0.94 (RRI[5%). It
was concluded that the ﬁndings strongly suggest that
survival beneﬁt is unlikely to be achieved with low-dose
steroids for patients with severe sepsis and/or septic
shock. In addition, the probabilities of developing serious
drug-induced side effects such as superinfections, bleed-
ing, and hyperglycemia are too high to justify shock
reversal as the sole indication for the use of low-dose
steroids.
The time course of organ failure in patients with septic
shock treated with hydrocortisone was analyzed in a study
that was an addendum of the Corticus trial [50]. The
authors hypothesized that patients treated with hydro-
cortisone when compared to placebo would have a faster
resolution of organ dysfunction/failure. The authors ana-
lyzed the patients who had been enrolled in the Corticus
trial: a prospective, randomized, double-blind, placebo-
controlled study of 28-day mortality in patients with
septic shock for less than 72 h who underwent a short
high-dose ACTH test and patients received 11-day treat-
ment with hydrocortisone or placebo. A total of 499
patients were enrolled (hydrocortisone 251, placebo 248).
There was no difference in 28-day mortality between the
two treatment groups (hydrocortisone 34.3 vs. placebo
31.5%). There was a decrease in the SOFA score of
hydrocortisone-treated patients from day 0 to day 7
compared with the placebo-treated patients (p = 0.0027),
driven by an improvement in cardiovascular organ dys-
function/failure (p = 0.0005) and in liver failure
(p\0.0001) in the hydrocortisone-treated patients. It was
concluded that patients treated with hydrocortisone
demonstrated a faster decrease in total organ dysfunction/
failure, without being accompanied by a decreased
mortality.
It is well known that sepsis is also an important cause
of morbidity and mortality for neonates, but a rapid and
accurate diagnostic is difﬁcult. A group of authors coor-
dinated by Falagas [51] aimed at assessing the value of
PCT for the diagnosis of neonatal sepsis by performing a
diagnostic test accuracy meta-analysis of relevant studies.
Twenty-nine articles were analyzed. The authors found a
sensitivity and speciﬁcity of 81% (95% CI 74–87%) and
79% (95% CI 69–87%), respectively. The area under the
receiver operating characteristic curve (AUC-ROC) was
0.87. However, high statistical heterogeneity was
observed for all analyses. It was concluded that although
serum PCT at presentation has very good diagnostic
351accuracy for the diagnosis of neonatal sepsis; the marked
heterogeneity along with the lack of a uniform deﬁnition
for neonatal sepsis, means that the interpretation of the
ﬁndings is to be done cautiously.
Polymerase chain reaction (PCR)-based techniques
allow more rapid and sensitive detection of pathogens
compared with conventional blood culture. The current
opinion is that PCR can supplement but not replace blood
culture in septic patients. A review article published in the
July issue [52] deals with these problems. Numerous
studies showed that the combined detection rate of both
methods (PCR and blood culture) was signiﬁcantly higher
compared with PCR or blood culture alone. An inherent
limitation of PCR is that determination of antibiotic
resistance can currently be performed only by blood
culture. PCR techniques are also costly and involve a
signiﬁcant workload. Except for diagnosis of patients in
whom unusual, not cultivable, or fastidious pathogens are
of concern, such as immunosuppressed patients with
suspected parasitic infection, it might even not be nec-
essary to further increase the spectrum of detectable
species. In the authors’ opinion, a narrower assay is more
cost effective, may achieve higher accuracy owing to
reduced intratest interference, and would better address
current and emerging clinical needs.
Phosphorylation pathways may be altered during severe
sepsis and septic shock. These pathways play a central role
in the development and progression of many other disease
states, because they control central biological mechanisms
in nearly all cellular functions. In a review published at the
beginning of 2011, Martin and Ranieri [53] summarized
the function and activity of various phosphorylation
mechanisms. The authors discussed the phosphorylation
mechanisms in the pathogenesis, diagnosis, and treatment
of heart failure, myocardial infarction, stroke, respiratory
failure, ventilation-induced lung injury, traumatic brain
injury, acute organ failure, systemic sepsis, and shock. It
was concluded that a proper understanding of these
mechanisms will provide new avenues of treatment by
targeting this biological function.
Gastrointestinal dysfunction in critically ill septic
patients is common, and probably underestimated. A
validated deﬁnition of acute intestinal failure is lacking, in
the absence of a marker to measure it. A review on gas-
trointestinal dysfunction in critically ill patients [54]
proposed a deﬁnition of acute intestinal failure. Small
bowel ischemia is related to acute reduction of enterocyte
mass and loss of gut barrier. Systemic inﬂammatory
response syndrome and sepsis could be linked to an acute
dysfunction of enterocytes without enterocyte reduction.
Citrulline is an amino acid mainly synthesized by small
bowel enterocytes. Patients with shock have an acute
reduction of enterocyte mass and reduced gut citrulline
synthesis, leading to a low plasma citrulline concentra-
tion. The authors proposed that acute intestinal failure
could be deﬁned as an acute reduction of enterocyte mass
and/or acute dysfunction of enterocytes, associated or not
with loss of gut barrier function. The authors also stated
that the value of plasmatic citrulline as an indicator of
acute intestinal failure in critically ill patients must be
further evaluated.
ICU organization and outcome
Organization
On behalf of the ESICM working group on quality
improvement, Valentin and Ferdinande [55] updated the
basic requirement for the planning or renovation of ICUs.
A total of 47 ICU physicians from 23 countries reviewed
all available literature and reached consensus through an
iterative process with several rounds. Although commu-
nication and team-working culture are not addressed, this
document provides operative guidelines and design rec-
ommendations that could help ICU directors ensure the
adequate practice of our specialty.
Rapid response teams (RRTs) might be very different
in terms of their activity and the characteristics of dete-
riorating patients in the ward. Jaderling and co-workers
[56] compared RRTs, one in a hospital in Austin (Aus-
tralia) and the other in Stockholm (Sweden). They found
that although the number of calls was higher in Austin,
the patients’ characteristics were grossly similar and
suggested that deteriorating patients are similar all over
the world in the hospital ward. Although the rates of
limitation of medical treatment decisions was about 30%
and not different between centers, the rate of ICU transfer
was 9.9% in Austin and 18.7% in Stockholm. The 30-day
mortality of both cohorts was high (27.7 vs. 29.4%).
Dehmel and co-workers [57] compared drug concen-
tration of amiodarone, norepinephrine, and hydro-
cortisone prepared manually and automatically, and mea-
sured by high-performance liquid chromatography. They
found that more than a half of manually prepared solutions
differed from the scheduled concentration by more than 5%.
Deviation of more than 15% occurred in 15% of manually
prepared solution. Particularly for norepinephrine, the
deviation was of at least 10% in 6 of the 30 (20%) manually
prepared solutions. Solutions prepared by automated pro-
cedure dramatically narrowed the deviation from the desired
concentration. The concentration of the machine-made
solution was 101.1 ± 4.3% of the desired solution.
Outcome
Gayat and co-workers [58] developed a severe post-par-
tum hemorrhage (SPHH) score based on two independent
cohorts of parturients in order to predict the need for an
advance interventional procedure (AIP) and optimize the
352referral of patients at risk to a specialized tertiary care
center. AIP was needed in 42 and 43% of the cases. They
found that abnormalities of placenta implantation, inter-
national normalized ratio greater than 1.64, low ﬁbrinogen
(less than 2 g/l), detectable levels of troponin, and heart
rate greater than 115 bpm were independent predictors of
the need for AIP. They built an SPHH score with one point
attributed for the presence of each risk factor. In an
external multicenter validation dataset, the AUC-ROC of
the score in predicting AIP was 0.818, indicating a good
discrimination. The risk of AIP was 11, 39, and 75% for an
SPHH score of 0, 1, and 2 or more, respectively.
In a very large cohort of ICU patients from 38 Aus-
tralian ICUs, Renton et al. [59] found that the rate of
readmission was 5.5% (13,598 out of 247,103 patients).
Readmissions were associated with a more than fourfold
increase in the post-ICU mortality. Discharge from ICU
between 6 p.m. and 6 a.m. (OR 1.13, 95% CI 1.13–1.19)
was the only factor accessible to improvement. It suggests
discharge at night could serve as a process indicator in
evaluating structural or organizational aspects of ICUs.
Health-related quality of life (HRQoL) after ICU stay
is fundamental in assessing the beneﬁts of ICU care.
Orwelius and co-workers [60] found that social integra-
tion inﬂuenced the post-ICU HRQoL, as assessed by SF-
36 questionnaire in post-ICU patients, but was not asso-
ciated with HRQoL in a reference group of people.
Therefore social integration needs to be examined in
parallel when comprehensive studies of post-ICU HRQoL
are undertaken.
Prognostic models have been designed to predict mor-
tality in general ICU populations. It is unclear whether these
models serve the same purpose in elderly patients. To
answer this question Minne et al. [61] performed a sys-
tematic review and identiﬁed seven studies. In total, 17
models were found of which six were developed for the
general adult ICU population and eleven speciﬁcally for
elderly patients. Cohorts ranged from 148 to 12,993 patients
and only smaller ones were obtained prospectively. The
AUC-ROC was most commonly used to measure perfor-
mance (range 0.71–0.88). The median number of criteria
met for clinical credibility was 4.5 out of 7 (range 2.5–5.5)
and 17 out of 20 for methodological quality (range 15–20).
It was concluded that there is no evidence that elderly-
speciﬁc models (those developed for elderly or very elderly
population) perform better than general models developed
for a general adult ICU population.
Education
Teaching intensive care medicine
The CoBaTrICE collaboration [62] developed an initial
set of 52 possible standards using a modiﬁed Delphi
process involving experts from 28 European countries.
This document might be a basic tool for a dynamic pro-
cess of quality improvement of the educational
environment in intensive care medicine.
Skills and behavior are fundamental in evaluating the
quality of a teaching process. Hunziker et al. [63] studied
the impact of emotions on the performance of fourth-year
medical students before, during, and after a simulated
resuscitation. They measured emotion using an 18-item
questionnaire. Negative emotions were irritation, disap-
pointment, guilt, shame, and anxiety, and positive
emotions of interest were pride, joy, pleasure, and relief.
They also measured the perceived stress, feeling of being
overwhelmed, and motivation on a ten-point Likert scale.
They evaluated the quality of performance on the simu-
lator as duration of uninterrupted chest compressions or
deﬁbrillation in the ﬁrst 180 s after the onset of cardiac
arrest. They found that negative emotions during resus-
citation were more frequent than before or after. In
contrast, positive emotions were less frequent. Students’
stress/overload increased during resuscitation (5.4 before
vs. 8.2 during resuscitation, p\0.0001, WS-ANOVA).
Interestingly, the quality of performance was negatively
inﬂuenced by stress/overload and positively inﬂuenced by
motivation during the early resuscitation phase. Negative
emotions did not remain associated with performance in
the ﬁnal model. The impact of stress coping and increased
motivation strategies to improve performance of resusci-
tation remains to evaluate.
The teaching process by lecture format is widely used
at congresses and in medical educational programs.
Lautrette et al. [64] wanted to assess the number of take-
home messages identiﬁed by postgraduate critical care
junior doctors (juniors) during lectures. The authors per-
formed a prospective observational study of 13 lectures.
Lecturers were not informed. At the end of the lecture, the
lecturer and juniors listed the three main take-home
messages on a form. Subjective elements of the juniors’
appraisal and objective elements of the lectures were also
recorded. Successful knowledge transfer was assessed by
matching lecturers’ and juniors’ take-home messages. A
total of 367 forms were analyzed. A match equal to 3
(highest match), 2, 1 or 0 was observed in 3.8, 26.7, 48.2,
and 21.2% of the forms, respectively. No single sub-
jective or objective element of the lecture was associated
with the number of identiﬁed take-home messages. It was
concluded that two-thirds of critical care junior doctors
identiﬁed at best only one of the three main take-home
messages of a lecture. These results suggest that there is a
need to develop strategies to improve the performance of
lecture-based learning.
The recognition of intensive care medicine (ICM) as
an independent specialty at the European level is a long
and difﬁcult process whose end is still far away. In a
special article published in December, Rubulotta and
colleagues [65] recapitulated the more recent and
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specialty at both the European and national levels and they
also described the impact of the lack of recognition on
training schemes throughout Europe and the subsequent
ability of trained specialists to then move between different
countries. The authors note that there is no harmonization
among European countries. Nations providing a national
examination for ICM and a national register for specialists
in ICM facilitate the free movement of specialists,
regardless of European regulations and directives. It was
concluded that ICM is currently not a mother specialty and
that a long process needs to occur before complete har-
monization of training and accreditation and free
movement of specialists in Europe will happen.
Ultrasonography
Ultrasonography is gaining a growing interest and
importance in critical care medicine. This year our journal
published several articles on the subject.
A group of 29 experts representing the ESICM and 11
other critical care societies proposed a framework for
organizing training in ultrasound techniques adapted to the
ICM setting [21]. It was recommended that intensive care
physicians should aim to achieve competencies in three
main areas: (1) general critical care ultrasound, (2) ‘‘basic’’
critical care echocardiography, and (3) advanced critical
care echocardiography. There was 100% agreement among
the experts that general critical care ultrasound and ‘‘basic’’
critical care echocardiography should be mandatory in the
curriculum of ICM physicians. It was recommended that
national intensive care societies play the role of supporting
the implementation of training in general critical care
ultrasound and basic critical care echocardiography in their
own countries.
The use of chest ultrasound is rapidly evolving and it is
proposed as a technique to look for pneumothorax. In the
February issue, Volpicelli [66] reviewed the current
knowledge on lung ultrasound targeted at the diagnosis of
pneumothorax and to provide experts’ opinion and personal
clinical experience. Ultrasound diagnosis of pneumothorax
relies on the recognition of four sonographic artifact signs:
the lung sliding, the B lines, the lung point, and the lung
pulse. Combining these few signs, it is possible to accu-
rately rule in or rule out pneumothorax at the bedside in
several different clinical scenarios. Sensitivity of a lung
ultrasound in the detection of pneumothorax is higher than
that of conventional anterior-posterior chest radiography
(CXR), and similar to that of computed tomography (CT). A
major beneﬁt of a lung ultrasound is that it can be used
quickly to diagnose pneumothorax at the bedside and does
not expose the patient to ionizing radiation. It was con-
cluded that lung ultrasound is the method of choice in
several common clinical situations.
The role of lung ultrasound in critically ill patients,
compared with bedside CXR, was evaluated by Xir-
ouchaki and colleague [67] using thoracic CT as a gold
standard. Forty-two mechanically ventilated patients
scheduled for CT were prospectively studied with a
modiﬁed lung ultrasound protocol. Four pathologic enti-
ties were evaluated: consolidation, interstitial syndrome,
pneumothorax, and pleural effusion. Eighty-four hemi-
thoraces were evaluated by the three imaging techniques.
The sensitivity, speciﬁcity, and diagnostic accuracy of
CXR were 38, 89, and 49% for consolidation, 46, 80, and
58% for interstitial syndrome, 0, 99, and 89% for pneu-
mothorax, and 65, 81, and 69% for pleural effusion,
respectively. The corresponding values for lung ultra-
sound were 100, 78, and 95% for consolidation, 94, 93,
and 94% for interstitial syndrome, 75, 93, and 92% for
pneumothorax, and 100, 100, and 100% for pleural
effusion, respectively, suggesting that lung ultrasound has
a considerably better diagnostic performance than CXR
for the diagnosis of common pathologic conditions and
may be used as an alternative to thoracic CT.
Ultrasonography has been also proposed to detect
intracranial hypertension. Invasive intracranial devices
are the gold standard for measuring the intracranial
pressure, but the technique is not free of risk. The ultra-
sonography of optic nerve sheath diameter has been
suggested as a possible indicator of intracranial hyper-
tension. Dubourg et al. [68] analyzed the data on the
accuracy of ultrasonography of optic nerve sheath diam-
eter with invasive measurements of intracranial pressure.
They performed a meta-analysis of six studies. No sig-
niﬁcant heterogeneity was detected. For detection of
raised intracranial pressure, the sensitivity was 0.90 and
speciﬁcity was 0.85. The AUC-ROC was 0.94. It was
concluded that ultrasonography of optic nerve sheath
diameter shows a good level of diagnostic accuracy for
detecting intracranial hypertension in adult patients with
traumatic brain injury and intracranial hemorrhage.
Ultrasonography may have the potential to decrease
the likelihood of aspiration of gastric contents during
urgent endotracheal intubation. An observational study
was carried out during 80 urgent endotracheal intubation
procedures in which left upper quadrant ultrasonography
was performed [69]. If gastric ﬂuid was identiﬁed during
ultrasonography, it was evacuated using a gastric tube. A
subsequent ultrasonography conﬁrmed removal of gastric
contents prior to induction. It was found that 19 (24%)
patients had gastric ﬂuid content identiﬁed and 13 (16%)
had sufﬁcient gastric ﬂuid content such that the caregivers
proceeded with gastric tube insertion. Gastric ﬂuid vol-
ume removed was 553 ± 290 mL and none of the
patients had a clinically consequential aspiration event. It
was concluded that ultrasonography is useful for the
detection of gastric ﬂuid and may reduce the risk of a
clinically consequential aspiration event during urgent
endotracheal intubation.
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Metabolism
Blood glucose variability might be associated
with mortality
Eslami et al. [70] analyzed 12 studies in a systematic review
aiming to identify glucose variability and its association
with mortality. The authors found that multiple indicators
were used to measure glucose variability, the most common
indicators being hypo- and hyperglycemia. All studies
reported a statistically signiﬁcant association between
mortality and at least one glucose variability indicator. It
was concluded that the independent association between
blood glucose level variabilitya n dm o r t a l i t yi su n s e t t l e d .
This result was attributed to the variability being analyzed in
very disparate ways and because of heterogeneity (in
methods, design, and reporting) among the different studies.
Some drugs currently used in critical care medicine might
have detrimental effects
Among them there is etomidate, an imidazole derivative, is
a fast-acting anesthetic agent for rapid sequence intubation,
but it is an inhibitor of adrenal 11b-hydroxylase. It may
cause adrenal dysfunction after a single bolus lasting for up
to 48 h. In a meta-analysis published in the June issue,
Albert and coauthors [71] assessed data of etomidate versus
comparator anesthetics for mortality and adrenal insufﬁ-
ciency. A total of 19 studies were included. Meta-analysis
showed a signiﬁcant increase in risk ratio for etomidate
versus non-etomidate with respect to mortality (risk ratio
1.19, p\0.001) and adrenal insufﬁciency (risk ratio 1.64,
p\0.001). They also found a marked heterogeneity
(I2 = 88% for adrenal insufﬁciency and I2 = 64% for
mortality), and studies were of moderate to low quality. It
was concluded that the association between etomidate and
adrenal insufﬁciency is strong and it is weak for mortality.
Coagulation
Coagulation abnormalities represent a constant danger in
the ICM world. For instance, massive bleeding following
traumatic injury is the second most common cause of
death in industrialized countries. In a systematic review of
230 articles published between January 2000 and August
2009, Lier and colleagues [72] provided recommenda-
tions for coagulation management in multiple trauma
patients. The authors discuss several diagnostic and
therapeutic approaches. It was concluded that for life-
threatening hemorrhage, the sole application of
fresh frozen plasma may not be sufﬁcient, and that
early, anticipatory therapy with packed red blood cells,
fresh frozen plasma, and puriﬁed factor concentrates
together with correction of concomitant abnormalities
(temperature, pH, ionized calcium) will help rescue more
patients.
Some coagulopathies are rare, but intensivists have to
be well aware that acquired hemophilia is, for example, a
rare condition in which inhibiting antibodies develop
against coagulation factors, most often factor VIII, and
leads to major bleeding requiring intensive care treatment.
Acquired hemophilia also has signiﬁcant mortality
(6–8%). A review article dealt with the diagnosis and
management of acquired hemophilia [73]. Recognition of
acquired hemophilia presents a clinical challenge, given
the rarity of this condition and the potential for confusion
with other more common causes of bleeding. An acute
onset of bleeding in a patient without history of bleeding
should raise suspicion of this disorder, particularly if the
patient is elderly or post-partum. The early laboratory
diagnosis is a prolongation of activated partial thrombo-
plastin time with normal prothrombin time and platelet
count. The treatment of acquired hemophilia is a multi-
step, physiologically focused process aimed at
controlling both active and recurrent bleeding. It
includes administration of human factor VIII concentrate,
desmopressin, inhibitor bypassing agents (recombinant
activated factor VII and plasma-derived activated
prothrombin complex concentrate), and eradication of
the inhibitor (plasmapheresis and immunoadsorp-
tion, and immunosuppressive treatment). A prompt
diagnosis is central to prognosis, and consultation with a
hematologist may facilitate efﬁcient diagnosis and
management.
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